Author(s):
Prasanthi Teella, Sri Nataraj Kalakonda, Rajeswari Saripilli
Email(s):
drsaripillirajeswaria@gmail.com , saripilli.rajeswari@cutm.ac.in
DOI:
10.52711/0974-360X.2024.00851 
Address:
Prasanthi Teella1, Sri Nataraj Kalakonda2, Rajeswari Saripilli3*
1Department of Pharmaceutical Technology, Aditya College of Pharmacy, Surampalem, Andhra Pradesh, India.
1Maharajah’s College of Pharmacy, Phool Baugh, Vizianagaram, Andhra Pradesh, India.
2Sri Vishnu College of Pharmacy, Bheemavaram - 534202, Andhra Pradesh, India.
3School of Pharmacy, Centurion University of Technology and Management, Balangir-767001, Odisha, India.
*Corresponding Author
Published In:
Volume - 17,
Issue - 11,
Year - 2024
ABSTRACT:
A cardiovascular diseaseis mainlyreason for one third of global deaths and which is a leading and increasing contributor to the global disease burden. Hypertension is another risk factor for heart disease and is the single most risk factor for stroke. Patients with diabetes are 2-4 times more likely suffering and/or die of coronary heart disease. The aim of the research investigation is to design and characterization of bilayer tablets for bimodal drug release. Valsartan is selected as a drug of choice for immediate release layer preparation and for sustained release layer preparation metformin hydrochloride was selected. Bilayer tablets were prepared by double compression procedure. Immediate release tablets are prepared by physical mixing procedure to improve the drug solubility. All the tablets were characterized by Differential scanning calorimetry, Fourier transform infrared, X-Ray diffraction, Scanning electron microscopy. Among the three immediate release formulations IF2 containing 4% sodium starch glycolate shows 84.46% drug release in 30 mins and 99.69% drug release in 1hr. Among all the six sustained release formulations SF3 shows 99.76±0.9% drug release for an extended period up to 12hrs. Both optimized layers were considered to formulate bilayer tablets by direct compression technique. From the results it was concluded that combination dosage form can be achieved by bilayer tablet, the prepared bilayer tablet containing 4% SSG shows immediate action with improved oral bioavailability from IR layer and 16% hydroxy propyl methyl cellulose K100 shows drug release for prolonged period of time with improved bioavailability.
Cite this article:
Prasanthi Teella, Sri Nataraj Kalakonda, Rajeswari Saripilli. Design and Characterization of bimodal Release Formulation of Valsartan and Metformin hydrochloride. Research Journal of Pharmacy and Technology. 2024; 17(11):5575-3. doi: 10.52711/0974-360X.2024.00851
Cite(Electronic):
Prasanthi Teella, Sri Nataraj Kalakonda, Rajeswari Saripilli. Design and Characterization of bimodal Release Formulation of Valsartan and Metformin hydrochloride. Research Journal of Pharmacy and Technology. 2024; 17(11):5575-3. doi: 10.52711/0974-360X.2024.00851 Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-11-59
REFERENCES:
1. OWiuous QL. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management ofhypertension. World Health Organization, International Society of Hypertension Writing Group. Journal of Hypertension. 2003; 21(1): 983-991. https://doi.org/10.1097/01.hjh.0000084751.37215.d2.
2. Wilson PW. Diabetes mellitus and coronary heart disease. American Journal of Kidney Diseases. 1998; Nov 1; 32(5): S89-100. https://doi.org/10.1053/ajkd.1998.v32.pm9820468.
3. Kalra S. Kalra B. Agrawal N. Combination therapy in hypertension: An update. Diabetology Metabolic Syndrome. 2010; 2(44): 2-11. https://doi.org/10.1186/1758-5996-2-44.
4. Gautam CS. Saha L. Fixed dose drug combinations (FDCs): Rational or irrational: A view point. British Journal of Clinical Pharmacology. 2008; 65(5): 795. doi: 10.1111/j.1365-2125.2007.03089.x.
5. Suresh E. Lambert CM. Combination treatment strategies in early rheumatoid arthritis. Annals of the Rheumatic Diseases. 2005; 64(9): 1252-1256. https://doi.org/10.1136/ard.2004.032219
6. Rao SV. Priyanka B. Padmalatha K. Bilayer tablet technology: A novel approach. GSC Biological and Pharmaceutical Sciences. 2019; 7(2). https://doi.org/10.30574/gscbps.2019.7.2.0033
7. Pradhan R. Kim SY. Yong CS. Kim JO. Preparation and characterization of spray-dried valsartan-loaded Eudragit® E PO solid dispersion microparticles. Asian Journal of Pharmaceutical Sciences. 2016; 11(6): 744-750. https://doi.org/10.1016/j.ajps.2016.05.002.
8. Chowdary KP. Rao KS. Madhuri D. A Factorial Study on the Effects of cyclodextrins, poloxamer 407 and PVP on the solubility and dissolution rate of etoricoxib. International Journal of Pharmacy and Pharmaceutical Sciences. 2011; 9(2): 672-686.
9. Tambe ST. Padekar HB.Dhobale SM. Jadhav SL. Design and characterization of bi-layer tablets containing simvastatin as sustained release and labetalol HCl as immediate release. Journal of Drug Delivery and Therapeutics. 2019; 9(2-s): 263-270. https://doi.org/10.22270/jddt.v9i2-s.2508
10. Syed IA. Patro C.Alshanberi AM. Ansari SA. Statistical designing and characterization of valsartan oral disintegrating tablet. Advancesin Pharmacology and Pharmacy. 2021; 9: 33-44. https://doi.org/10.13189/app.2021.090301.
11. Keshari A. Tripathi PK. Srivastava A. Vishwas R. Formulation and evaluation of effervecent floating tablets of antidiabetic drug. Journal of Drug Delivery and Therapeutics. 2015; 5(6): 43-55. https://doi.org/10.22270/jddt.v5i6.1176.
12. Roy H. Brahma CK. Nandi S. Parida KR. Formulation and design of sustained release matrix tablets of metformin hydrochloride: Influence of hypromellose and polyacrylate polymers. International Journal of Applied and Basic Medical Research. 2013; 3(1): 55-63. https://doi.org/10.4103/2229-516X.112242.
13. Kalpna M. Dev D. Shahnaz M. Parkash J. Prasad DN. Preparation of controlled release metformin hydrochloride loaded chitosan microspheres and evalaution of formulation parameters. Journal of Drug Delivery and Therapeutics. 2018; 8(5-s): 378-387. https://doi.org/10.22270/jddt.v8i5-s.1995
14. Mandal U. Pal TK. Formulation and in vitro studies of a fixed-dose combination of a bilayer matrix tablet containing metformin HCl as sustained release and glipizide as immediate release. Drug Development and Industrial Pharmacy. 2008; 34(3): 305-313. https://doi.org/10.1080/03639040701657487.
15. Chinta R. Rohini P. Formulation development of empagliflozin and metformin hydrochloride extended release tablets: Optimization of Formulation using statistical experimental design. Research Journal of Pharmacy and Technology. 2021; 14(3): 1201-1208. https://doi.org/10.5958/0974-360X.2021.00214.6.
16. Lanjhiyana SK. Polysaccharides based novel and controlled released multiparticulate systems for colon-specific delivery: Contemporary scenario and future prospects. Asian Journal of Pharmaceutics. 2020; 14(4): 488-498. https://doi.org/10.22377/ajp.v14i4.3815.
17. Rajeswari S. Sravya K. Murthy KVR. Development, formulation and evaluation of a bilayer gastric retentive floating tablets of ranitidine HCl and clarithromycin using natural polymers. International Journal of Pharmacy and Pharmaceutical Sciences. 2017; 9 (9): 164-177. http://dx.doi.org/10.22159/ijpps.2017v9i9.20290.
18. Hari K. Bhavani C. Rajeswari P. Rajeswari S. Vasavi G.Formulation and evaluation of bilayer floating tablets of atorvastatin and captopril. International Journal of Pharmaceutical Sciences and Research. 2020; 11(9): 4676-4690. http://dx.doi.org/10.13040/IJPSR.0975-8232.11(9).4676-90.
19. Wagh R. Jani R. Design, Characterization and Evaluate Self Pore forming Osmotic Tablet containing combination of Antidiabetic and Antihypertensive Drugs. Neuro Quantology. 2022; 20(9): 3871. DOI:10.14704/nq.2022.20.9.nq44444.
20. Prasanna RI, Anitha P, Chetty CM. Formulation and evaluation of bucco-adhesive tablets of sumatriptan succinate. International Journal of Pharmaceutical Investigation. 2011; 1(3): 182-191. https://doi.org/10.4103/2230-973X.85971.
21. Shinde GS, Rahul KG, Jadhav R. Quantitative estimation and validation of metformin hydrochloride and gliclazide in their tablet dosage form by RP-HPLC. Research Journal of Science and Technology. 2019; 11(3): 201-207. https://doi.org/10.5958/2349-2988.2019.00030.5.
22. Gedawy A. Al-Salami H. Dass CR. Development and validation of a new analytical HPLC method for simultaneous determination of the antidiabetic drugs, metformin and gliclazide. Journal of Food and Drug Analysis. 2019; 27(1): 315-322. https://doi.org/10.1016/j.jfda.2018.06.007
23. Patil OA. Patil IS.Bilsakar VV.Randive DS. Bhutkar MA.Bhinge SD. Formulation and evaluation of valsartan pulsincap drug delivery system for treatment of hypertension. Asian Journal of Pharmacy and Technology. 2018; 8(2): 65-70. https://doi,org/10.5958/2231-5713.2018.00010.7.
24. Garala K. Joshi P. Shah M.Ramkishan A. Patel J. Formulation and evaluation of periodontal in situ gel. International Journal of Pharmaceutical Investigation. 2013; 3(1): 29-41. DOI. 10.4103/2230-973X.108961.
25. Husseiny RA. Lila AS. Abdallah MH. El-ghamry HA. Fast disintegrating tablet of Valsartan for the treatment of pediatric hypertension: In vitro and in vivo evaluation. Journal of Drug Delivery Science and Technology. 2018; 43: 194-200. https://doi.org/10.1016/j.jddst.2017.10.014.
26. Chaud MV. Lima AC. Vila MM. Paganelli MO. Paula FC.Pedreiro LN.Gremião MP. Development and evaluation of praziquantel solid dispersions in sodium starch glycolate. Tropical Journal of Pharmaceutical Research. 2013; 12(2): 163-168.http://doi.org/10.4314/tjpr.v12i2.5.
27. Barot BS, Parejiya PB, Patel TM, Parikh RK, Gohel MC. Development of directly compressible metformin hydrochloride by spray drying technique. Acta Pharmaceutica. 2010; 60(2): 165-175. https://doi.org/10.2478/v10007-010-0016-9.
28. Fadheel QJ. A comparative study of the effect of metformin and metformin plus garlic on blood glucose level in patients with type 2 diabetes mellitus in Iraq. Research Journal of Pharmacy and Technology. 2019; 12(4): 1806-1810. https://doi.org/10.5958/0974-360X.2019.00301.9.
29. Patil SA. Kuchekar BS. Chabukswar AR. Jagdale SC. Formulation and evaluation of extended-release solid dispersion of metformin HCl. Journal of Young Pharmacists. 2010; 2(2): 121-129. https://doi.org/10.4103/0975-1483.63147
30. Pradhan R. Kim SY. Yong CS. Kim JO. Preparation and characterization of spray-dried valsartan-loaded Eudragit® E PO solid dispersion microparticles. Asian Journal of Pharmaceutical Sciences. 2016; 11(6): 744-750. https://doi.org/10.1016/j.ajps.2016.05.002.
31. Panda TK. Das D. Panigrahi L. Formulation development of solid dispersions of bosentan using Gelucire 50/13 and Poloxamer 188. Journal of Applied Pharmaceutical Science. 2016; 6(9): 027-033. DOI: 10.7324/JAPS.2016.60904
32. Munir R. Hadi A. Khan SU. Asghar S. Irfan M. Khan IU. Hameed M. Inam S. Islam N. Hassan SF. Ishtiaq M. Solubility and dissolution enhancement of dexibuprofen with hydroxypropyl betacyclodextrin (HPβCD) and poloxamers (188/407) inclusion complexes: preparation and in vitro characterization. Polymers. 2022; 14(3): 579. https://doi.org/10.3390/polym14030579
33. Tran TTD. Tran PHL. Park JB. Lee BJ. Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan. Archives of Pharmacal Research. 2012; 35: 1223–1230. https://doi.org/10.1007/s12272-012-0713-7.
34. Reddy MR. Gubbiyappa KS. A systematic review on supersaturable self-nano emulsifying drug delivery system: a potential strategy for drugs with poor oral bioavailability. International Journal of Applied Pharmaceutics. 2022; 14(3): 16-33. https://dx.doi.org/10.22159/ijap.2022v14i3.44178.
35. Raza H. Javeria S. Rashid Z. Sustained released Metformin microparticles for better management of type II diabetes mellitus: In-vitro studies. Materials Research Express. 2020; 7(1): 015343. https://doi.org.10.1088/2053-1591/ab6c0f.
36. Bhise SB. Rajkumar M. Effect of HPMC on solubility and dissolution of carbamazepine form III in simulated gastrointestinal fluids. Asian Journal of Pharmaceutics. 2008; 2(1): 38-42. https://doi.org/10.22377/ajp.v2i1.170
37. Sung KC. Nixon PR. Skoug JW. Ju TR. Gao P. Topp EM. Patel MV. Effect of formulation variables on drug and polymer release from HPMC-based matrix tablets. International Journal of Pharmaceutics. 1996; 142(1): 53-60. https://doi.org/10.1016/0378-5173(96)04644-3.
38. Yang Y. Huang Z. Zhang X. Li J. Huang Y. Chen W. Pan X. Wu C. Development of paroxetine hydrochloride single layer controlled-release tablets based on 32 factorial design. Pharmaceutics. 2018; 10(4): 243. https://doi.org/10.3390/pharmaceutics10040243.
39. Kaushal A. Arora S. Sharma N. Singh S. Development of bilayer tablet containing saxagliptin immediate release and metformin sustained release using quality by design approach. Current Drug Therapy. 2021; 16(2): 184-203. https://doi.org/10.2174/1574885516666210315100848.
40. Pandit V. Pai RS. Devi K. Suresh S. In vitro-in vivo evaluation of fast-dissolving tablets containing solid dispersion of pioglitazone hydrochloride. Journal of Advanced Pharmaceutical Technology and Research. 2012; 3(3): 160-70. https://doi.org/10.4103/2231-4040.101008.
41. Sundararajan G. Stephen P. Raja M.Umapoorani T. Formulation development and evaluation of bilayer tablets containing rosuvastatin as immediate release and metformin hydrochloride as sustained release.World Journal of Pharmacy and Pharmaceutical Sciences. 2019; 8(8): 932-945. https://doi.org/10.20959/wjpps20198-14355.
42. Kumari DS. Balasubramaniam V. Velrajan G. Deepthi N. Sushma R. Formulation and evaluation of bilayer floating tablets of metformin hydrochloride and glibenclamide. Research Journal of Pharmacy and Technology. 2013; 6(1): 105-111.